Intellectual Property Protection in Cosmetic Manufacturing Agreements

Map the IP before you negotiate: what actually exists in a cosmetic project

Most disputes come from parties who never listed what they were protecting. A cosmetic project generates more distinct intellectual assets than buyers expect, and each one can have a different owner. Before any negotiation, write them down.

• **The formula:** the ingredient list with percentages and the processing method. This may be the factory's base formula, a modified version of it, or a formula you brought. Each case has a different natural owner.
• **Know-how:** process parameters, stabilisation tricks, supplier choices for raw materials. Often undocumented and often the factory's most valuable asset.
• **Brand assets:** your trademark, logo, product names, taglines and brand colours.
• **Artwork and packaging design:** label files, carton dielines, custom moulds for bottles or caps, decoration specifications.
• **Test data and regulatory filings:** stability, safety and efficacy reports, and any notification or registration made with the authorities, which may be in the factory's name.
• **Specifications:** finished product specification, method of analysis, acceptance criteria. Generated during product development, usually jointly.
• **Customer and commercial data:** your sales channels, pricing, forecasts and distributor lists that the factory sees through orders.

For each asset, answer three questions: who created it, who paid for it, and who needs to use it after the relationship ends. The answers usually reveal where the agreement has to be explicit. A buyer bringing an in-house formula wants absolute ownership of the formula and specifications; a buyer using the factory's base wants the right to continue selling the product and to move production, which is a different negotiation. Buyers running global sourcing programmes across several factories often keep a standard IP schedule and attach it to every agreement, so the asset map is consistent across suppliers.

Formula ownership: the clause that decides whether you can ever leave

The formula clause is where the long-term economics of the relationship sit. Three ownership models are common in Thai cosmetic manufacturing, and the agreement should state clearly which one applies to each product.

• **Factory-owned base formula (ODM):** the factory developed the formula before you arrived and offers it to multiple brands. You get a licence to sell products made from it, usually non-exclusive. You cannot take the formula to another factory. Advantages: speed and low development cost. Risk: if the relationship ends, you need a new formula and a reformulation that customers may notice.
• **Buyer-owned formula (OEM):** you supply the formula or pay for custom development with a clear assignment of rights. The factory manufactures to it and must not use it for others. You can move production, subject to the know-how issue below. Advantage: control. Cost: development fees and the responsibility for testing.
• **Jointly developed formula:** the factory modifies its base to your brief. Ownership is genuinely ambiguous unless written down. Common compromises: the buyer owns the modifications and the specific finished formula, the factory keeps its base; or the buyer obtains an exclusive licence for a territory or period, with a right to buy the formula outright at a stated price.

Whatever the model, the agreement should define the formula by reference to a document (a formula sheet with a version number, held in escrow or exchanged under confidentiality), state who owns it, state whether the factory may use it for other customers, and say what happens to the formula and its documentation on termination. A separate point is often missed: owning the formula on paper is not the same as being able to reproduce it. Ask for the processing instructions and critical parameters to be delivered with the formula sheet, so that another facility could in principle make the product. Factories reasonably resist handing over process know-how; a middle path is a sealed technical file released only on defined exit events.

Confidentiality that works in practice, not only on paper

A non-disclosure agreement signed before the first meeting is standard, but confidentiality in manufacturing fails for operational reasons more than legal ones: the brief is forwarded to a raw-material supplier, the artwork sits on a shared drive, a sales representative shows your sample to another prospect as an example of capability. The agreement should set obligations that a factory can actually implement, and you should verify during audit that it does.

Elements worth including:

• **Definition of confidential information** covering formulas, specifications, artwork, launch plans, pricing and the fact of the relationship itself if you prefer it undisclosed.
• **Permitted recipients:** named functions within the factory (R&D, QA, production planning) and approved subcontractors such as testing laboratories or packaging printers, each bound by equivalent terms.
• **Handling rules:** no samples shown to third parties, no display of your products in showrooms or trade-fair booths without consent, no use of your brand in the factory's marketing or client lists unless agreed.
• **Raw-material supplier disclosure:** when the factory sources an ingredient to your specification, it may need to share part of the brief; limit this to what the supplier needs.
• **Duration:** obligations that survive termination for a defined period, longer for formulas and know-how than for commercial data.
• **Return or destruction** of documents and samples at exit, with written confirmation.

On the factory floor, look for the operational signs: are customer documents access-controlled, are development samples labelled with codes rather than brand names, is there a visitor policy that keeps prospects out of areas where your packaging is visible? A factory that handles confidentiality well usually also runs good product development discipline, because both rely on document control. If you find your products on display during a visit, raise it; it is a common and fixable gap rather than a reason to walk away, but it tells you the clause needs operational backing.

Trademarks, artwork and moulds: ownership of the visible brand

Buyers tend to assume the brand is obviously theirs. Legally that is only true if the trademark is registered in the relevant jurisdictions and the artwork and tooling are assigned. Three practical issues arise in Thai cosmetic manufacturing.

**Trademark registration in Thailand.** If your product is made in Thailand, a Thai trademark registration gives you standing against local misuse, including a situation where a third party registers your brand first. Registration is handled by the Thai Department of Intellectual Property; a local agent can file. Consider filing early, before the brand appears on supplier documents and samples. The agreement should state that the factory acquires no rights in your marks and may not register anything confusingly similar.

**Artwork and design files.** If the factory's designers produce your labels and cartons, the default position in many jurisdictions is that the creator owns the copyright unless assigned. Include an assignment of all artwork, dielines and design files created for your products, with delivery of editable source files at exit. If you bring your own designer, make sure your own contract with that designer contains the same assignment.

**Custom moulds and tooling.** A custom bottle or cap mould is a physical asset. State who paid for it, who owns it, where it is kept, and whether you may remove it to another supplier. Tooling that stays with the packaging supplier under the factory's account is a common lock-in; ask for the mould to be registered in your name with the packaging vendor if you funded it.

**Regulatory filings in the factory's name.** Where the factory is the legal notifier or licence holder, the brand name appears on a filing you do not own. Agree in writing that the factory will cooperate with transfer or withdrawal on exit, and that you may obtain copies of the filing at any time. This single provision prevents the most common post-termination standoff.

Exclusivity, non-compete and copycat risk: what is reasonable to ask

Buyers often ask for broad exclusivity and factories often refuse, which stalls negotiations. The useful approach is to separate the real concern, a copycat product appearing from the same factory, from the maximal ask.

Reasonable positions that factories commonly accept:

• **Product-level exclusivity:** the factory will not supply the same formula, or a formula developed from your modifications, to another customer. This is the core protection for a buyer-owned or jointly developed formula and should be standard.
• **Category and territory limits:** exclusivity for a defined product category in defined markets for a defined period, often tied to a minimum annual volume so the factory is not locked out of a category by a small customer.
• **No look-alike packaging:** the factory will not produce for others a product whose get-up is confusingly similar to yours. Hard to enforce precisely, but it sets the expectation.

Positions that are usually unrealistic or counterproductive:

• Asking a factory to stop serving an entire category it already serves for others.
• Non-compete terms with no volume commitment.
• Exclusivity that extends to the factory's base formulas offered to the market before you arrived.

Also consider the reverse: factories sometimes ask buyers for exclusivity, meaning you may not manufacture the product elsewhere. Resist that for a buyer-owned formula unless the factory offers a meaningful commitment in return, such as priority capacity. Independent product development consultants in Thailand can help benchmark what is normal for your category. If you are comparing several candidates from a Thai manufacturers directory or a B2B platform such as THAIMOST (thaimost.com), raise exclusivity and formula ownership in the first conversation; a factory's answer tells you a great deal about how it treats other customers' IP.

Exit terms and a buyer's verification checklist

The quality of an IP clause is measured at exit. Agreements that read well while everyone is cooperating frequently fall silent on what happens when orders stop. Write the exit before you need it.

Termination provisions to include:

• Delivery of the formula sheet, specifications, methods of analysis and process parameters for buyer-owned or jointly owned products, in a defined format and within a defined period after notice.
• Cooperation with transfer or withdrawal of regulatory filings held in the factory's name, with costs allocated.
• Release of custom tooling and remaining branded packaging components, and either a final production run or a buy-back of components at agreed terms.
• Continued confidentiality for the agreed survival period, and destruction or return of your documents.
• A short transition period during which the factory continues to supply while production moves, if either side wishes to use it.

Before signing, verify the factory can honour the clause, not just agree to it:

• Does the factory maintain version-controlled formula sheets and process records per customer? Ask to see the system with a neutral example.
• Are customer samples and documents coded rather than branded in R&D and QA areas?
• Can it name the subcontractors (labs, printers, packaging suppliers) that will see your information, and confirm they are under written confidentiality?
• Has it transferred a product to another customer or facility before, and how was the handover documented?
• Is the entity signing the agreement the same entity that holds the manufacturing licence and will hold any filing?

A factory that answers these calmly and shows documents is usually one whose operational discipline matches the contract. The same questions apply if the partner is a supplement manufacturer or a full-service production manager that coordinates partner factories; in that structure, confirm which entity holds each asset and how obligations flow down to the facility doing the work. Then have counsel review the final text in both languages if the Thai version will govern.